An Integrated Multiplexing Approach Identifies IDO1 as a Biomarker for Recurrence of Rare Ovarian Granulosa Cell Tumors
An Integrated Multiplexing Approach for the Immunoprofiling of the Tumor Microenvironment of Ovarian Granulosa Cell Tumors
The ever-changing world of gene fusions in cancer: a secondary gene fusion and progression
EBV–Associated Lymphoproliferative Disorders: Update in Classification
Using a Multiplexed Immunofluorescence Approach to Compare Immune Cell Populations in Subtypes on Non-Small Cell Lung Cancer
Clinicopathologic characteristics and novel biomarkers of aggressive B-cell lymphomas in the nasopharynx
Predictive Markers Require Thorough Analytic Validation
Comparison of diagnostic methodologies to detect chromosomal abnormalities.